Search Results - A. S. Ostrovskaya
- Showing 1 - 14 results of 14
-
1
Plagiarism in the XXI Century: Who Needs It? by A. S. Ostrovskaya
Published 2016-06-01Plagiarism is perhaps the most common form of unethical behaviour, when the author of the published material (not always intentionally or consciously) uses fragments or even the whole work of another researcher without getting the permission, not accompanying matching content with references to the...
Get full text
Article -
2
MODERN ASPECTS OF ACUTE RESPIRATORY DISEASES TREATMENT IN CHILDREN: TOPICAL DRUGS IN RHINOPHARYNGITIS by A. S. Ostrovskaya, S. A. Ivanichkin
Published 2012-09-01The issues of acute respiratory diseases treatment in children, including the most common mistakes in management of such patients, unreasonable from the etiopathogenic point of view treatment with systemic antibacterial drugs and advantages of the topical therapy in arresting of the inflammatory pro...
Get full text
Article -
3
SPECIFICS OF DRUG PHARMACOKINETICS IN PREGNANCY by A.V. Ostrovskaya, S.A. Sher
Published 2010-09-01Applying clinical pharmacology guidelines to the mother-fetus system makes it possible to better understand the specifics of pharmacokinetics during pregnancy. The article illustrates the factors that drive these specific features related to both changes in the boy of a future mother and the presenc...
Get full text
Article -
4
SELECTION OF ANTIBACTERIAL PREPARATIONS IN PREGNANCY by S.A. Sher, A.V. Ostrovskaya
Published 2011-01-01The article focuses on issues related to the selection of drugs in infection processes during pregnancy. To eliminate fetal risk or mitigate it a rational selection of drugs and their optimal dosage are required. It provides key groups of antimicrobial drugs ranked by their safety for the fetus unde...
Get full text
Article -
5
EVALUATION OF POTENTIAL RISK POSED BY MEDICATIONS TO THE FETUS by S.A. Sher, A.V. Ostrovskaya
Published 2010-05-01The article focuses on the issue of evaluating potential risk posed by medications to the fetus during pregnancy. For this purpose various countries use classifications of medications broken down into risk categories during pregnancy. The most popular classification is US FDA classification, which i...
Get full text
Article -
6
ISSUES OF FETUS DRUG SAFETY by A.V. Ostrovskaya, S.A. Sher
Published 2010-02-01The article is focused on the issue of fetus drug safety. Development of a child’s health depends both on hereditary information and environment factors. The reason for deviation from the process of normal prenatal development could be any xenobiotics, physical factors and some medications having a...
Get full text
Article -
7
EUROPEAN TERATOLOGY INFORMATION SERVICE: EXPERIENCE, PROBLEMS AND PERSPECTIVES by A.V. Ostrovskaya, K. Schefer, L. von Stackelberg
Published 2007-10-01Congenital malformations are still the important medical and social issue. They take the second place among the reasons for the infant mortality and cause up to 18,3% of disablement cases among the children. Exogenous factors, effecting the growing fetus, are very essential along with the genetic ma...
Get full text
Article -
8
Research of emotional personal sphere and coping strategies of persons with epilepsy by Ye. V. Karavayeva, A. V. Ostrovskaya, N. G. Katayeva
Published 2011-04-01This work is devoted to identifying the relationship between disorders of emotional personal sphere of persons with temporal lobe epilepsy and their preferred coping strategies. The objects of the study were 40 people, including 20 patients with verified diagnosis of temporal lobe epilepsy who are t...
Get full text
Article -
9
CYTOKINE PROFILE IN COMPLICATIONS OF HORMONE THERAPY ADMINISTERED FOR UTERINE FIBROIDS by N. F. Khvorostukhina, A. E. Ostrovskaya, D. A. Novichkov, N. N. Stepanova
Published 2017-12-01Uterine fibroids take a second place in the structure of gynecological diseases, after inflammation of genital organs, with a share of 40%. The aim of the study was to investigate cytokine profile and factors of immune dysfunction in patients with uterine fibroids complicated by hemorrhagic syndrome...
Get full text
Article -
10
Competitve Growth: the Development of Key Competences and Corporate Venturing by A. I. Kashirin, V. V. Strenalyuk, A. S. Semennov, A. A. Ostrovskaya, T. V. Kokuytseva
Published 2016-12-01The article is based on the hypothesis that formation, keeping and development of organization’s key competences each reflecting the competitive advantage is the most important condition for business’ competitive growth. With scientific and technical acceleration, formation of new highly technologic...
Get full text
Article -
11
A 19-year-old Patient with Recurrent Pruritus and Jaundice by K. S. Nezhdanov, E. N. Shirokova, Yu. O. Shulpekova, A. S. Ostrovskaya, M. S. Zharkova, V. T. Ivashkin
Published 2023-09-01Аim: to highlight the importance of broad differential diagnosis and possibility of conversion of benign recurrent intrahepatic cholestasis type 2 into more aggressive clinical phenotype.Key points. A 19-year-old female patient was admitted to the Clinic with skin pruritus, jaundice, dark urine, cla...
Get full text
Article -
12
PREVENTIVE STRATEGIES IN THE STAGES OF FORMATION AND COURSE OF BRONCHOPULMONARY DYSPLASIA by I. V. Davydova, L. S. Namazova-Baranova, G. V. Yatsyk, N. A. Mayanskiy, E. P. Zimina, A. S. Ostrovskaya
Published 2014-03-01Prevention of development of bronchopulmonary dysplasia (BPD) and possibility of preventing severe course of the disease are the first-priority areas of neonatal pulmonology. Use of modern medical technologies allows protecting a premature infant’s respiratory system from as early as antenatal perio...
Get full text
Article -
13
Challenges in Diagnosing Intrahepatic Cholangiolithiasis in a 39-Year-Old Patient by A. K. Guseva, O. N. Sergeyeva, T. P. Nekrasova, O. T. Imaraliev, A. V. Okhlobystin, Y. N. Shirokova, A. S. Ostrovskaya, M. S. Zharkova, A. S. Cherenda, V. T. Ivashkin
Published 2024-12-01Aim: to highlight the challenges of diagnosing and treating a patient with severe intrahepatic cholangiolithiasis.Key points. Primary sclerosing cholangitis is a chronic progressive liver disease characterized by destructive inflammation and fibrosis in the bile ducts, leading to biliary strictures,...
Get full text
Article -
14
Diagnostic and Prognostic Value of Hyperammonemia in Patients with Liver Cirrhosis, Hepatic Encephalopathy, and Sarcopenia (Experts’ Agreement) by M. Yu. Nadinskaia, M. V. Maevskaya, I. G. Bakulin, E. N. Bessonova, A. O. Bueverov, M. S. Zharkova, S. V. Okovityi, A. S. Ostrovskaya, K. A. Gulyaeva, V. T. Ivashkin
Published 2024-03-01Introduction. In cirrhotic patients, hyperammonemia develops due to impaired ammonia detoxification and portosystemic blood shunting and is most commonly associated with hepatic encephalopathy and sarcopenia. Currently, there are questions regarding the diagnosis of hyperammonemia and the effect of...
Get full text
Article